Sign Up Today and Learn More About Spyglass Pharma Stock
Invest in or calculate the value of your shares in Spyglass Pharma or other pre-IPO companies through EquityZen's platform.
Spyglass Pharma Stock (SPPH)
Spyglass Pharma provides medicine for ophthalmic diseases.
About Spyglass Pharma Stock
Founded
2019
Headquarters
Aliso Viejo, CA, US
Industries
Travel and Tourism, Space, Transportation
Spyglass Pharma Press Mentions
Stay in the know about the latest news on Spyglass Pharma
SpyGlass Pharma Files $100M IPO
ocbj • Jan 22, 2026
AgomAb and Spyglass push the IPO button
pharmaphorum • Jan 21, 2026
SpyGlass Pharma Announces First Patients Randomized in SGP-005 and SGP-006, Two Registrational Phase III Clinical Trials of Its Novel BIM-IOL System
globenewswire • Jan 20, 2026
2026 IPO Train Keeps Chugging as AgomAb, SpyGlass Eye Nasdaq Debut
biospace • Jan 19, 2026
Chronic eye condition biotech SpyGlass Pharma files for a $100 million IPO
renaissancecapital • Jan 17, 2026
Spyglass Pharma Management
Leadership team at Spyglass Pharma
Co-Founder and CTO
Glenn Sussman
CEO
Patrick Mooney
Join now and verify your accreditation status to gain access to:
- Spyglass Pharma Current Valuation
- Spyglass Pharma Stock Price
- Spyglass Pharma Management
- Available deals in Spyglass Pharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Spyglass Pharma Cap Table and Funding History by Share Class and Liquidity Preferences
- Spyglass Pharma Revenue and Financials
- Spyglass Pharma Highlights
- Spyglass Pharma Business Model
- Spyglass Pharma Risk Factors
- Spyglass Pharma Research Report from SACRA Research
Trading Spyglass Pharma Stock
How to invest in Spyglass Pharma stock?
Accredited investors can buy pre-IPO stock in companies like Spyglass Pharma through EquityZen funds. These investments are made available by existing Spyglass Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Spyglass Pharma stock?
Shareholders can sell their Spyglass Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 420K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
